PERFALGAN - risultati della ricerca

Unione Europea - italiano - EMA (European Medicines Agency)

lenalidomide krka d.d.

krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - immunosoppressori - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) è indicato per il trattamento di pazienti adulti con mieloma multiplo precedentemente non trattato e che non sono idonei per il trapianto. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bortezomib koanaa

koanaa healthcare gmbh - bortezomib - bortezomib

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

alkeran 2 mg compresse rivestite con film

aspen pharma schweiz gmbh - melphalanum - compresse rivestite con film - melphalanum 2 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, e 171, pro compresso obducto. - farmaco - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bortezomib mylan

mylan s.p.a. -

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bortezomib sandoz

sandoz s.p.a. -

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bortezomib sandoz gmbh

sandoz gmbh - bortezomib - bortezomib

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bortezomib mylan

mylan s.p.a. - bortezomib - bortezomib